Genetics of pheochromocytoma;Genetik der Phäochromozytome

Chirurg

Volumn 83, Issue 6, 2012, Pages 511-518

  Bausch, B ^a   Malinoc, A ^a   Maruschke, L ^a   Offergeld, C ^a   Glasker S ^a   Rischke, H C ^a   Brauckhoff, M ^b   Boedeker, C C ^a   Neumann, H P H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Hereditary pheochromocytoma; Molecular genetic; Paraganglioma; Pheochromocytoma; Pheochromocytoma associated syndromes

Indexed keywords

ADOLESCENT; ADRENAL TUMOR; ADULT; AGED; ARTICLE; CHILD; FEMALE; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE DETECTION; HUMAN; INFANT; MALE; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PHEOCHROMOCYTOMA; PRESCHOOL CHILD; SYNDROME;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HETEROZYGOTE DETECTION; HUMANS; INFANT; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; SYNDROME; YOUNG ADULT;

EID: 84862501535     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-011-2191-8     Document Type: Article

References (29)

1. Anonymous (1988) Neurofibromatosis. Conference statement. National institutes of health consensus development conference. Arch Neurol 45:575-578
2. Astuti D, Ricketts CJ, Chowdhury R et al (2010) Mutation analysis of HIF prolyl hydroxylases (PHD/ EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility. Endocr Relat Cancer 18:73-83
3. Bausch B, Borozdin W, Mautner VF et al (2007) Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab 92:2784-2792
4. Bausch B, Borozdin W, Neumann HP (2006) Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma. N Engl J Med 354:2729-2731
5. Bayley JP, Kunst HP, Cascon A et al (2010) SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol 11:366- 372
6. Burnichon N, Briere JJ, Libe R et al (2010) SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 19:3011-3020
7. Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F et al (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 43:663-667
8. DeLellis RA, Heitz PU, Lloyd RV, Eng C (Hrsg) (2003) Pathology and molecular genetics of endocrine tumours (WHO classification of tumours of endocrine organs). IARC Press, Lyon
9. Frank-Raue K, Rybicki LA, Erlic Z et al (2011) Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germli- ne RET mutations located in exon 10. Hum Mutat 32:51-58
10. Gutmann DH, Aylsworth A, Carey JC et al (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57
11. Hao HX, Khalimonchuk O, Schraders M et al (2009) SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325:1139-1142
12. Hensen EF, Jordanova ES, Minderhout IJ van et al (2004) Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 23:4076-4083
13. Kloos RT, Eng C, Evans DB et al (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565-612
14. Malinoc A, Sullivan M, Wiech T et al (2012) Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3. Endocr Relat Cancer [Epub ahead of print]
15. Mannelli M, Castellano M, Schiavi F et al (2009) Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/ or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab 94:1541-1547
16. Mannelli M, Ercolino T, Giache V et al (2007) Genetic screening for pheochromocytoma: should SDHC gene analysis be included J Med Genet 44:586-587
17. Milos IN, Frank-Raue K, Wohllk N et al (2008) Age- related neoplastic risk profiles and penetrance es- timations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC > TGG) mutation. Endocr Relat Cancer 15:1035-1041
18. Munirajan AK, Ando K, Mukai A et al (2008) KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death. J Biol Chem 283:24426-24434
19. Neumann H (2008) Pheochromocytoma. In: Fauci A, Longo DL, Braunwald E (Hrsg) Harrison's prin- ciples of internal medicine, 17. Aufl. McGraw-Hill Professional
20. Neumann HP, Bausch B, McWhinney SR et al (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459-1466
21. Neumann HP, Pawlu C, Peczkowska M et al (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292:943-951
22. Peczkowska M, Cascon A, Prejbisz A et al (2008) Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation. Nat Clin Pract Endocrinol Metab 4:111-115
23. Qin Y, Yao L, King EE et al (2010) Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 42:229-233
24. Schussheim DH, Skarulis MC, Agarwal SK et al (2001) Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrinol Metab 12:173-178
25. Tischler AS (2008) Pheochromocytoma and extraadrenal paraganglioma: updates. Arch Pathol Lab Med 132:1272-1284
26. Vanharanta S, Buchta M, McWhinney SR et al (2004) Early-onset renal cell carcinoma as a no- vel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet 74:153-159
27. Walther MM, Herring J, Enquist E et al (1999) von Recklinghausen's disease and pheochromocytomas. J Urol 162:1582-1586
28. Wohllk N, Schweizer H, Erlic Z et al (2010) Multiple endocrine neoplasia type 2. Best Pract Res Clin Endocrinol Metab 24:371-387
29. Yao L, Schiavi F, Cascon A et al (2010) Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. JAMA 304:2611-2619